Risks and Benefits of Conducting Preclinical Studies in the Global Setting

Posted 01 December 2011 | By Mukesh KumarPhDRACJanice LongstrethDABT

It is generally accepted that the preclinical studies needed for first-in-man clinical studies usually take one to three years and cost up to $10 million USD, and the preclinical studies needed for market approval application cost about $70-$90 million.1

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe